Last 12 months
Inside the activity.
0 purchase rows · 204 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 17 |
| Dec 2025 | 0 | 26 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 8 |
| Jun 2026 | 0 | 32 |
| Jul 2026 | 0 | 64 |
| Aug 2026 | 0 | 27 |
| Sep 2026 | 0 | 20 |
| Oct 2026 | 0 | 5 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 04, 2019 Filed Mar 6, 2019 23:32 UTC |
OYLER JOHNDirector · Chief Executive Officer
|
SaleAmerican Depositary Shares | 300 | $154.38 | $46,313.01 |
DisclosureSEC source: 0001651308-19-000022 · wf-form4_155191513982829.xml · nonDerivative · entry 13 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F13 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $154.11 to $154.65, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. F10 · ownership.nature: These securities are held in a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 23:32 UTC |
OYLER JOHNDirector · Chief Executive Officer
|
SaleAmerican Depositary Shares | 1,700 | $152.57 | $259,364.07 |
DisclosureSEC source: 0001651308-19-000022 · wf-form4_155191513982829.xml · nonDerivative · entry 12 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 300 F1 · security: Each American Depositary Share represents 13 Ordinary Shares F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.14 to $153.07, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. F10 · ownership.nature: These securities are held in a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 23:32 UTC |
OYLER JOHNDirector · Chief Executive Officer
|
SaleAmerican Depositary Shares | 1,700 | $151.61 | $257,729.01 |
DisclosureSEC source: 0001651308-19-000022 · wf-form4_155191513982829.xml · nonDerivative · entry 11 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,000 F1 · security: Each American Depositary Share represents 13 Ordinary Shares F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $151.10 to $152.09, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. F10 · ownership.nature: These securities are held in a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 23:32 UTC |
OYLER JOHNDirector · Chief Executive Officer
|
SaleAmerican Depositary Shares | 6,090 | $150.77 | $918,219.14 |
DisclosureSEC source: 0001651308-19-000022 · wf-form4_155191513982829.xml · nonDerivative · entry 10 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 3,700 F1 · security: Each American Depositary Share represents 13 Ordinary Shares F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.07 to $151.06, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. F10 · ownership.nature: These securities are held in a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 23:32 UTC |
OYLER JOHNDirector · Chief Executive Officer
|
SaleAmerican Depositary Shares | 200 | $154.51 | $30,902.00 |
DisclosureSEC source: 0001651308-19-000022 · wf-form4_155191513982829.xml · nonDerivative · entry 5 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $154.37 to $154.65, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 23:32 UTC |
OYLER JOHNDirector · Chief Executive Officer
|
SaleAmerican Depositary Shares | 200 | $153.66 | $30,731.00 |
DisclosureSEC source: 0001651308-19-000022 · wf-form4_155191513982829.xml · nonDerivative · entry 4 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200 F1 · security: Each American Depositary Share represents 13 Ordinary Shares F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $153.20 to $154.11, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 23:32 UTC |
OYLER JOHNDirector · Chief Executive Officer
|
SaleAmerican Depositary Shares | 1,686 | $152.51 | $257,132.53 |
DisclosureSEC source: 0001651308-19-000022 · wf-form4_155191513982829.xml · nonDerivative · entry 3 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400 F1 · security: Each American Depositary Share represents 13 Ordinary Shares F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.14 to $153.07, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 23:32 UTC |
OYLER JOHNDirector · Chief Executive Officer
|
SaleAmerican Depositary Shares | 2,502 | $151.34 | $378,660.94 |
DisclosureSEC source: 0001651308-19-000022 · wf-form4_155191513982829.xml · nonDerivative · entry 2 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,086 F1 · security: Each American Depositary Share represents 13 Ordinary Shares F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $151.00 to $151.94, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:08 UTC |
Wang XiaodongDirector
|
SaleAmerican Depositary Shares | 1,000 | $150.00 | $150,000.00 |
DisclosureSEC source: 0001651308-19-000020 · wf-form4_155182008138055.xml · nonDerivative · entry 10 Wang Xiaodong · CIK 0001662982 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:08 UTC |
Wang XiaodongDirector
|
SaleAmerican Depositary Shares | 200 | $154.07 | $30,814.00 |
DisclosureSEC source: 0001651308-19-000020 · wf-form4_155182008138055.xml · nonDerivative · entry 9 Wang Xiaodong · CIK 0001662982 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · ownership.nature: These securities are held by Wang Investment LLC, of which 99% of the limited liability company interest is owned by two grantor retained annuity trusts, of which the Reporting Person's wife is a trustee, for which the Reporting Person disclaims beneficial ownership. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:08 UTC |
Wang XiaodongDirector
|
SaleAmerican Depositary Shares | 200 | $152.92 | $30,584.00 |
DisclosureSEC source: 0001651308-19-000020 · wf-form4_155182008138055.xml · nonDerivative · entry 8 Wang Xiaodong · CIK 0001662982 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 200 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · ownership.nature: These securities are held by Wang Investment LLC, of which 99% of the limited liability company interest is owned by two grantor retained annuity trusts, of which the Reporting Person's wife is a trustee, for which the Reporting Person disclaims beneficial ownership. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:08 UTC |
Wang XiaodongDirector
|
SaleAmerican Depositary Shares | 600 | $152.14 | $91,282.02 |
DisclosureSEC source: 0001651308-19-000020 · wf-form4_155182008138055.xml · nonDerivative · entry 7 Wang Xiaodong · CIK 0001662982 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 400 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $151.82 to $152.60, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. F4 · ownership.nature: These securities are held by Wang Investment LLC, of which 99% of the limited liability company interest is owned by two grantor retained annuity trusts, of which the Reporting Person's wife is a trustee, for which the Reporting Person disclaims beneficial ownership. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:08 UTC |
Wang XiaodongDirector
|
SaleAmerican Depositary Shares | 1,000 | $150.00 | $150,000.00 |
DisclosureSEC source: 0001651308-19-000020 · wf-form4_155182008138055.xml · nonDerivative · entry 6 Wang Xiaodong · CIK 0001662982 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,000 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · ownership.nature: These securities are held by Wang Investment LLC, of which 99% of the limited liability company interest is owned by two grantor retained annuity trusts, of which the Reporting Person's wife is a trustee, for which the Reporting Person disclaims beneficial ownership. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:08 UTC |
Wang XiaodongDirector
|
SaleAmerican Depositary Shares | 200 | $147.51 | $29,502.00 |
DisclosureSEC source: 0001651308-19-000020 · wf-form4_155182008138055.xml · nonDerivative · entry 5 Wang Xiaodong · CIK 0001662982 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,000 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $147.42 to $147.60, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. F4 · ownership.nature: These securities are held by Wang Investment LLC, of which 99% of the limited liability company interest is owned by two grantor retained annuity trusts, of which the Reporting Person's wife is a trustee, for which the Reporting Person disclaims beneficial ownership. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:08 UTC |
Wang XiaodongDirector
|
SaleAmerican Depositary Shares | 200 | $145.95 | $29,190.00 |
DisclosureSEC source: 0001651308-19-000020 · wf-form4_155182008138055.xml · nonDerivative · entry 4 Wang Xiaodong · CIK 0001662982 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,200 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · ownership.nature: These securities are held by Wang Investment LLC, of which 99% of the limited liability company interest is owned by two grantor retained annuity trusts, of which the Reporting Person's wife is a trustee, for which the Reporting Person disclaims beneficial ownership. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:08 UTC |
Wang XiaodongDirector
|
SaleAmerican Depositary Shares | 200 | $143.58 | $28,716.00 |
DisclosureSEC source: 0001651308-19-000020 · wf-form4_155182008138055.xml · nonDerivative · entry 3 Wang Xiaodong · CIK 0001662982 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,400 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · ownership.nature: These securities are held by Wang Investment LLC, of which 99% of the limited liability company interest is owned by two grantor retained annuity trusts, of which the Reporting Person's wife is a trustee, for which the Reporting Person disclaims beneficial ownership. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:08 UTC |
Wang XiaodongDirector
|
SaleAmerican Depositary Shares | 100 | $139.46 | $13,946.00 |
DisclosureSEC source: 0001651308-19-000020 · wf-form4_155182008138055.xml · nonDerivative · entry 2 Wang Xiaodong · CIK 0001662982 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,600 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · ownership.nature: These securities are held by Wang Investment LLC, of which 99% of the limited liability company interest is owned by two grantor retained annuity trusts, of which the Reporting Person's wife is a trustee, for which the Reporting Person disclaims beneficial ownership. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:08 UTC |
Wang XiaodongDirector
|
SaleAmerican Depositary Shares | 1,300 | $138.53 | $180,090.95 |
DisclosureSEC source: 0001651308-19-000020 · wf-form4_155182008138055.xml · nonDerivative · entry 1 Wang Xiaodong · CIK 0001662982 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,700 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $138.44 to $139.41, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. F4 · ownership.nature: These securities are held by Wang Investment LLC, of which 99% of the limited liability company interest is owned by two grantor retained annuity trusts, of which the Reporting Person's wife is a trustee, for which the Reporting Person disclaims beneficial ownership. Read SEC document |
| December 18, 2018 Filed Dec 19, 2018 23:34 UTC |
Peterson Amy C.CMO, Immuno-oncology
|
Exercise / conversionShare Option (Right to Buy) · Derivative | 131,833 | $0.00 Strike: $2.24 | $0.00 |
DisclosureSEC source: 0001651308-18-000018 · wf-form4_154526243150998.xml · derivative · entry 17 Peterson Amy C. · CIK 0001682735 · CMO, Immuno-oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 820,000 Underlying: Ordinary Shares · 131,833 shares Expires 2026-08-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F16 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. F17 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of August 22, 2016 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. All unvested shares subject to this option are subject to accelerated vesting upon certain termination events. Read SEC document |
| December 18, 2018 Filed Dec 19, 2018 23:34 UTC |
Peterson Amy C.CMO, Immuno-oncology
|
SaleAmerican Depositary Shares | 611 | $135.54 | $82,816.28 |
DisclosureSEC source: 0001651308-18-000018 · wf-form4_154526243150998.xml · nonDerivative · entry 15 Peterson Amy C. · CIK 0001682735 · CMO, Immuno-oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F15 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.40 to $136.3999, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| December 18, 2018 Filed Dec 19, 2018 23:34 UTC |
Peterson Amy C.CMO, Immuno-oncology
|
SaleAmerican Depositary Shares | 3,600 | $134.81 | $485,315.64 |
DisclosureSEC source: 0001651308-18-000018 · wf-form4_154526243150998.xml · nonDerivative · entry 14 Peterson Amy C. · CIK 0001682735 · CMO, Immuno-oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 611 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F14 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $134.37 to $135.3699, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| December 18, 2018 Filed Dec 19, 2018 23:34 UTC |
Peterson Amy C.CMO, Immuno-oncology
|
SaleAmerican Depositary Shares | 2,402 | $133.88 | $321,585.04 |
DisclosureSEC source: 0001651308-18-000018 · wf-form4_154526243150998.xml · nonDerivative · entry 13 Peterson Amy C. · CIK 0001682735 · CMO, Immuno-oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,211 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F13 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $133.32 to $134.3199, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| December 18, 2018 Filed Dec 19, 2018 23:34 UTC |
Peterson Amy C.CMO, Immuno-oncology
|
SaleAmerican Depositary Shares | 1,897 | $132.70 | $251,735.31 |
DisclosureSEC source: 0001651308-18-000018 · wf-form4_154526243150998.xml · nonDerivative · entry 12 Peterson Amy C. · CIK 0001682735 · CMO, Immuno-oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,613 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $132.22 to $133.2199, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| December 18, 2018 Filed Dec 19, 2018 23:34 UTC |
Peterson Amy C.CMO, Immuno-oncology
|
SaleAmerican Depositary Shares | 1,631 | $131.74 | $214,859.79 |
DisclosureSEC source: 0001651308-18-000018 · wf-form4_154526243150998.xml · nonDerivative · entry 11 Peterson Amy C. · CIK 0001682735 · CMO, Immuno-oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,510 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $131.01 to $132.0099, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| December 18, 2018 Filed Dec 19, 2018 23:34 UTC |
Peterson Amy C.CMO, Immuno-oncology
|
Exercise / conversionAmerican Depositary Shares | 10,141 | $29.10 | $295,103.10 |
DisclosureSEC source: 0001651308-18-000018 · wf-form4_154526243150998.xml · nonDerivative · entry 10 Peterson Amy C. · CIK 0001682735 · CMO, Immuno-oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,141 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · price: The exercise price is represented in American Depositary Shares. Read SEC document |
| December 17, 2018 Filed Dec 19, 2018 23:34 UTC |
Peterson Amy C.CMO, Immuno-oncology
|
Exercise / conversionShare Option (Right to Buy) · Derivative | 128,167 | $0.00 Strike: $2.24 | $0.00 |
DisclosureSEC source: 0001651308-18-000018 · wf-form4_154526243150998.xml · derivative · entry 16 Peterson Amy C. · CIK 0001682735 · CMO, Immuno-oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 951,833 Underlying: Ordinary Shares · 128,167 shares Expires 2026-08-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F16 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. F17 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of August 22, 2016 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. All unvested shares subject to this option are subject to accelerated vesting upon certain termination events. Read SEC document |
| December 17, 2018 Filed Dec 19, 2018 23:34 UTC |
Peterson Amy C.CMO, Immuno-oncology
|
SaleAmerican Depositary Shares | 480 | $136.93 | $65,726.40 |
DisclosureSEC source: 0001651308-18-000018 · wf-form4_154526243150998.xml · nonDerivative · entry 9 Peterson Amy C. · CIK 0001682735 · CMO, Immuno-oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $136.65 to $137.6499, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. Read SEC document |
| December 17, 2018 Filed Dec 19, 2018 23:34 UTC |
Peterson Amy C.CMO, Immuno-oncology
|
SaleAmerican Depositary Shares | 2,296 | $136.24 | $312,817.60 |
DisclosureSEC source: 0001651308-18-000018 · wf-form4_154526243150998.xml · nonDerivative · entry 8 Peterson Amy C. · CIK 0001682735 · CMO, Immuno-oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 480 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.61 to $136.6099, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. Read SEC document |
| December 17, 2018 Filed Dec 19, 2018 23:34 UTC |
Peterson Amy C.CMO, Immuno-oncology
|
SaleAmerican Depositary Shares | 778 | $135.04 | $105,064.70 |
DisclosureSEC source: 0001651308-18-000018 · wf-form4_154526243150998.xml · nonDerivative · entry 7 Peterson Amy C. · CIK 0001682735 · CMO, Immuno-oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,776 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $134.60 to $135.5999, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. Read SEC document |
| December 17, 2018 Filed Dec 19, 2018 23:34 UTC |
Peterson Amy C.CMO, Immuno-oncology
|
SaleAmerican Depositary Shares | 1,005 | $133.81 | $134,478.55 |
DisclosureSEC source: 0001651308-18-000018 · wf-form4_154526243150998.xml · nonDerivative · entry 6 Peterson Amy C. · CIK 0001682735 · CMO, Immuno-oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,554 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $133.43 to $134.4299, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. Read SEC document |
| December 17, 2018 Filed Dec 19, 2018 23:34 UTC |
Peterson Amy C.CMO, Immuno-oncology
|
SaleAmerican Depositary Shares | 1,700 | $132.91 | $225,953.29 |
DisclosureSEC source: 0001651308-18-000018 · wf-form4_154526243150998.xml · nonDerivative · entry 5 Peterson Amy C. · CIK 0001682735 · CMO, Immuno-oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,559 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $132.42 to $133.4199, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. Read SEC document |
| December 17, 2018 Filed Dec 19, 2018 23:34 UTC |
Peterson Amy C.CMO, Immuno-oncology
|
SaleAmerican Depositary Shares | 2,700 | $131.80 | $355,852.44 |
DisclosureSEC source: 0001651308-18-000018 · wf-form4_154526243150998.xml · nonDerivative · entry 4 Peterson Amy C. · CIK 0001682735 · CMO, Immuno-oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,259 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $131.38 to $132.3799, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. Read SEC document |
| December 17, 2018 Filed Dec 19, 2018 23:34 UTC |
Peterson Amy C.CMO, Immuno-oncology
|
SaleAmerican Depositary Shares | 900 | $130.37 | $117,331.02 |
DisclosureSEC source: 0001651308-18-000018 · wf-form4_154526243150998.xml · nonDerivative · entry 3 Peterson Amy C. · CIK 0001682735 · CMO, Immuno-oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,959 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $130.16 to $131.1599, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. Read SEC document |
| December 17, 2018 Filed Dec 19, 2018 23:34 UTC |
Peterson Amy C.CMO, Immuno-oncology
|
Exercise / conversionAmerican Depositary Shares | 9,859 | $29.10 | $286,896.90 |
DisclosureSEC source: 0001651308-18-000018 · wf-form4_154526243150998.xml · nonDerivative · entry 2 Peterson Amy C. · CIK 0001682735 · CMO, Immuno-oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,859 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · price: The exercise price is represented in American Depositary Shares. Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 22:28 UTC |
OYLER JOHNDirector · Chief Executive Officer
|
SaleAmerican Depositary Shares | 400 | $137.64 | $55,054.00 |
DisclosureSEC source: 0001651308-18-000015 · wf-form4_154465366908629.xml · nonDerivative · entry 10 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $137.33 to $138.3299, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. F1 · ownership.nature: These securities are held by Oyler Investment LLC, of which 99% of the limited liability company interest is owned by a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership. Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 22:28 UTC |
OYLER JOHNDirector · Chief Executive Officer
|
SaleAmerican Depositary Shares | 1,307 | $136.65 | $178,601.16 |
DisclosureSEC source: 0001651308-18-000015 · wf-form4_154465366908629.xml · nonDerivative · entry 9 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 400 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $136.30 to $137.2999, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. F1 · ownership.nature: These securities are held by Oyler Investment LLC, of which 99% of the limited liability company interest is owned by a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership. Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 22:28 UTC |
OYLER JOHNDirector · Chief Executive Officer
|
SaleAmerican Depositary Shares | 1,171 | $135.70 | $158,901.66 |
DisclosureSEC source: 0001651308-18-000015 · wf-form4_154465366908629.xml · nonDerivative · entry 8 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,707 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.28 to $136.2799, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. F1 · ownership.nature: These securities are held by Oyler Investment LLC, of which 99% of the limited liability company interest is owned by a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership. Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 22:28 UTC |
OYLER JOHNDirector · Chief Executive Officer
|
SaleAmerican Depositary Shares | 860 | $134.74 | $115,877.17 |
DisclosureSEC source: 0001651308-18-000015 · wf-form4_154465366908629.xml · nonDerivative · entry 7 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,878 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $134.12 to $135.1199, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. F1 · ownership.nature: These securities are held by Oyler Investment LLC, of which 99% of the limited liability company interest is owned by a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership. Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 22:28 UTC |
OYLER JOHNDirector · Chief Executive Officer
|
SaleAmerican Depositary Shares | 400 | $133.57 | $53,429.00 |
DisclosureSEC source: 0001651308-18-000015 · wf-form4_154465366908629.xml · nonDerivative · entry 6 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 3,738 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $133.00 to $133.9999, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. F1 · ownership.nature: These securities are held by Oyler Investment LLC, of which 99% of the limited liability company interest is owned by a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership. Read SEC document |
| December 03, 2018 Filed Dec 4, 2018 22:35 UTC |
Wang XiaodongDirector
|
SaleAmerican Depositary Shares | 100 | $163.84 | $16,384.00 |
DisclosureSEC source: 0001651308-18-000012 · wf-form4_154396291679328.xml · nonDerivative · entry 8 Wang Xiaodong · CIK 0001662982 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $163.84 to $164.8399, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. Read SEC document |
| December 03, 2018 Filed Dec 4, 2018 22:35 UTC |
Wang XiaodongDirector
|
SaleAmerican Depositary Shares | 100 | $159.50 | $15,950.00 |
DisclosureSEC source: 0001651308-18-000012 · wf-form4_154396291679328.xml · nonDerivative · entry 7 Wang Xiaodong · CIK 0001662982 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $159.50 to $160.4999, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. Read SEC document |
| December 03, 2018 Filed Dec 4, 2018 22:35 UTC |
Wang XiaodongDirector
|
SaleAmerican Depositary Shares | 100 | $156.79 | $15,679.00 |
DisclosureSEC source: 0001651308-18-000012 · wf-form4_154396291679328.xml · nonDerivative · entry 6 Wang Xiaodong · CIK 0001662982 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.79 to $157.7899, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. Read SEC document |
| December 03, 2018 Filed Dec 4, 2018 22:35 UTC |
Wang XiaodongDirector
|
SaleAmerican Depositary Shares | 300 | $155.53 | $46,659.99 |
DisclosureSEC source: 0001651308-18-000012 · wf-form4_154396291679328.xml · nonDerivative · entry 5 Wang Xiaodong · CIK 0001662982 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $155.41 to $156.4099, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. Read SEC document |
| December 03, 2018 Filed Dec 4, 2018 22:35 UTC |
Wang XiaodongDirector
|
SaleAmerican Depositary Shares | 400 | $154.19 | $61,674.00 |
DisclosureSEC source: 0001651308-18-000012 · wf-form4_154396291679328.xml · nonDerivative · entry 4 Wang Xiaodong · CIK 0001662982 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $153.74 to $154.7399, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. Read SEC document |
| December 03, 2018 Filed Dec 4, 2018 22:35 UTC |
Wang XiaodongDirector
|
SaleAmerican Depositary Shares | 529 | $152.87 | $80,867.12 |
DisclosureSEC source: 0001651308-18-000012 · wf-form4_154396291679328.xml · nonDerivative · entry 3 Wang Xiaodong · CIK 0001662982 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.59 to $153.5899, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. Read SEC document |
| December 03, 2018 Filed Dec 4, 2018 22:35 UTC |
Wang XiaodongDirector
|
SaleAmerican Depositary Shares | 800 | $151.98 | $121,584.00 |
DisclosureSEC source: 0001651308-18-000012 · wf-form4_154396291679328.xml · nonDerivative · entry 2 Wang Xiaodong · CIK 0001662982 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,529 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $151.49 to $152.4899, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. Read SEC document |
| December 03, 2018 Filed Dec 4, 2018 22:35 UTC |
Wang XiaodongDirector
|
SaleAmerican Depositary Shares | 2,671 | $150.98 | $403,262.77 |
DisclosureSEC source: 0001651308-18-000012 · wf-form4_154396291679328.xml · nonDerivative · entry 1 Wang Xiaodong · CIK 0001662982 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,329 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.36 to $151.3599, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. Read SEC document |
| November 28, 2018 Filed Nov 29, 2018 00:26 UTC |
OYLER JOHNDirector · Chief Executive Officer
|
SaleAmerican Depositary Shares | 800 | $149.67 | $119,734.00 |
DisclosureSEC source: 0001651308-18-000010 · wf-form4_154345117115026.xml · nonDerivative · entry 26 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 4,138 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F27 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.47 to $150.4699, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. F1 · ownership.nature: These securities are held by Oyler Investment LLC, of which 99% of the limited liability company interest is owned by a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership. Read SEC document |
| November 28, 2018 Filed Nov 29, 2018 00:26 UTC |
OYLER JOHNDirector · Chief Executive Officer
|
SaleAmerican Depositary Shares | 2,190 | $148.88 | $326,044.79 |
DisclosureSEC source: 0001651308-18-000010 · wf-form4_154345117115026.xml · nonDerivative · entry 25 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 4,938 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F26 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.36 to $149.3599, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. F1 · ownership.nature: These securities are held by Oyler Investment LLC, of which 99% of the limited liability company interest is owned by a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership. Read SEC document |
| November 28, 2018 Filed Nov 29, 2018 00:26 UTC |
OYLER JOHNDirector · Chief Executive Officer
|
SaleAmerican Depositary Shares | 1,000 | $147.82 | $147,816.00 |
DisclosureSEC source: 0001651308-18-000010 · wf-form4_154345117115026.xml · nonDerivative · entry 24 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 7,128 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F25 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $147.31 to $148.3099, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. F1 · ownership.nature: These securities are held by Oyler Investment LLC, of which 99% of the limited liability company interest is owned by a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.